SLC2A3 Gene

HGNC Family	Solute carriers (SLC)
Name	solute carrier family 2 (facilitated glucose transporter), member 3
Description	Enables D-glucose binding activity; dehydroascorbic acid transmembrane transporter activity; and hexose transmembrane transporter activity. Involved in D-glucose import across plasma membrane; galactose transmembrane transport; and transport across blood-brain barrier. Located in aggresome and plasma membrane. Biomarker of Alzheimer's disease; acanthosis nigricans; diabetes mellitus; and type 2 diabetes mellitus. [provided by Alliance of Genome Resources, Mar 2025]
Summary	{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nSLC2A3, which encodes the high‐affinity glucose transporter GLUT3, is critical for maintaining energy supply in cells challenged by limited extracellular glucose. In neuronal and brain tumor settings, GLUT3 ensures that cells—especially brain tumor–initiating cells and neurons facing excitotoxic or hypoxic stress—secure a competitive advantage by rapidly scavenging available glucose. Structural studies have detailed its substrate‐binding features and conformational dynamics, while clinical investigations have linked aberrantly high GLUT3 expression with poor outcomes in glioblastoma and even with altered neurophysiological responses in disorders such as attention‐deficit/hyperactivity disorder."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "5"}]}, {"type": "t", "text": "\n\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn a variety of extracerebral malignancies—including endometrial, breast, bladder, and head and neck cancers—up‐regulation of SLC2A3/GLUT3 is associated with poorly differentiated tumor subtypes and enhanced glycolytic metabolism. This overexpression facilitates increased glucose uptake even under nutrient‐stress conditions, thereby contributing to tumor progression and malignant aggressiveness. In addition, metastatic colorectal cancers exhibit GLUT3‐dependent acceleration of nucleotide synthesis and tumor invasiveness, underscoring its role as a metabolic driver in cancer."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "6", "end_ref": "10"}]}, {"type": "t", "text": "\n\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nThe expression of SLC2A3 is tightly controlled by multiple regulatory mechanisms that enable cells to adapt their metabolism to environmental cues. Hypoxia‐inducible factor–1, AMP‐activated protein kinase, and cAMP response element–binding protein (often modulated by microRNAs such as miR‑195‑5p) together modulate transcription and surface translocation of GLUT3 in diverse cell types. Moreover, recent findings implicate long noncoding transcripts—such as NICI—in a HIF‑dependent regulatory loop governing SLC2A3 expression, thereby linking alterations in epigenetic and transcriptional networks to metabolic reprogramming."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "11", "end_ref": "14"}]}, {"type": "t", "text": "\n\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond cancer and the nervous system, GLUT3 plays pivotal roles in normal physiology. Its expression in leukocytes supports robust immune activation under hypoglycemic stress, while in placental trophoblasts and other developmental tissues the regulated expression of SLC2A3 helps to ensure adequate nutrient transfer and energy homeostasis. In addition, studies in endothelial and embryonic stem cells reveal that dynamic modulation of GLUT3 facilitates cell motility and the maintenance of pluripotency when oxygen and glucose are limited."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "15", "end_ref": "19"}]}, {"type": "t", "text": "\n\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Petronela Weisová, Caoimhín G Concannon, Marc Devocelle, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Regulation of glucose transporter 3 surface expression by the AMP-activated protein kinase mediates tolerance to glutamate excitation in neurons."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Neurosci (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1523/JNEUROSCI.0354-09.2009"}], "href": "https://doi.org/10.1523/JNEUROSCI.0354-09.2009"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19261894"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19261894"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Ying Liu, Fei Liu, Inge Grundke-Iqbal, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Brain glucose transporters, O-GlcNAcylation and phosphorylation of tau in diabetes and Alzheimer's disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Neurochem (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1471-4159.2009.06320.x"}], "href": "https://doi.org/10.1111/j.1471-4159.2009.06320.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19659459"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19659459"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "K-P Lesch, S Selch, T J Renner, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genome-wide copy number variation analysis in attention-deficit/hyperactivity disorder: association with neuropeptide Y gene dosage in an extended pedigree."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Psychiatry (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/mp.2010.29"}], "href": "https://doi.org/10.1038/mp.2010.29"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20308990"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20308990"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "William A Flavahan, Qiulian Wu, Masahiro Hitomi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Brain tumor initiating cells adapt to restricted nutrition through preferential glucose uptake."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Neurosci (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nn.3510"}], "href": "https://doi.org/10.1038/nn.3510"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23995067"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23995067"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Dong Deng, Pengcheng Sun, Chuangye Yan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Molecular basis of ligand recognition and transport by glucose transporters."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nature (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nature14655"}], "href": "https://doi.org/10.1038/nature14655"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26176916"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26176916"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Fernanda Rocha Rojas Ayala, Rafael Malagoli Rocha, Kátia Cândido Carvalho, et al. "}, {"type": "b", "children": [{"type": "t", "text": "GLUT1 and GLUT3 as potential prognostic markers for Oral Squamous Cell Carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Molecules (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3390/molecules15042374"}], "href": "https://doi.org/10.3390/molecules15042374"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20428049"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20428049"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Xiang Fei, Manlong Qi, Bin Wu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-195-5p suppresses glucose uptake and proliferation of human bladder cancer T24 cells by regulating GLUT3 expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FEBS Lett (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.febslet.2012.01.006"}], "href": "https://doi.org/10.1016/j.febslet.2012.01.006"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22265971"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22265971"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Anna Krzeslak, Katarzyna Wojcik-Krowiranda, Ewa Forma, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression of GLUT1 and GLUT3 glucose transporters in endometrial and breast cancers."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pathol Oncol Res (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s12253-012-9500-5"}], "href": "https://doi.org/10.1007/s12253-012-9500-5"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22270867"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22270867"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Chih-Chia Kuo, Hsiang-Hsi Ling, Ming-Chen Chiang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Metastatic Colorectal Cancer Rewrites Metabolic Program Through a Glut3-YAP-dependent Signaling Circuit."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Theranostics (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.7150/thno.32915"}], "href": "https://doi.org/10.7150/thno.32915"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31131051"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31131051"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Weixing Dai, Ye Xu, Shaobo Mo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "GLUT3 induced by AMPK/CREB1 axis is key for withstanding energy stress and augments the efficacy of current colorectal cancer therapies."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Signal Transduct Target Ther (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41392-020-00220-9"}], "href": "https://doi.org/10.1038/s41392-020-00220-9"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32873793"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32873793"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Yuchang Fu, Lidia Maianu, Barry R Melbert, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Facilitative glucose transporter gene expression in human lymphocytes, monocytes, and macrophages: a role for GLUT isoforms 1, 3, and 5 in the immune response and foam cell formation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood Cells Mol Dis (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bcmd.2003.09.002"}], "href": "https://doi.org/10.1016/j.bcmd.2003.09.002"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14757434"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14757434"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Imari Mimura, Masaomi Nangaku, Yasuharu Kanki, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Dynamic change of chromatin conformation in response to hypoxia enhances the expression of GLUT3 (SLC2A3) by cooperative interaction of hypoxia-inducible factor 1 and KDM3A."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Biol (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1128/MCB.06643-11"}], "href": "https://doi.org/10.1128/MCB.06643-11"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22645302"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22645302"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Yang Liu, Yun-ming Li, Rui-feng Tian, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The expression and significance of HIF-1alpha and GLUT-3 in glioma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Brain Res (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.brainres.2009.09.083"}], "href": "https://doi.org/10.1016/j.brainres.2009.09.083"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19782666"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19782666"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Victoria Lauer, Steffen Grampp, James Platt, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Hypoxia drives glucose transporter 3 expression through hypoxia-inducible transcription factor (HIF)-mediated induction of the long noncoding RNA NICI."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.RA119.009827"}], "href": "https://doi.org/10.1074/jbc.RA119.009827"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31690629"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31690629"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "A Mobasheri, G Neama, S Bell, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Human articular chondrocytes express three facilitative glucose transporter isoforms: GLUT1, GLUT3 and GLUT9."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Biol Int (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1006/cbir.2001.0850"}], "href": "https://doi.org/10.1006/cbir.2001.0850"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11991658"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11991658"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Marc U Baumann, Stacy Zamudio, Nicholas P Illsley "}, {"type": "b", "children": [{"type": "t", "text": "Hypoxic upregulation of glucose transporters in BeWo choriocarcinoma cells is mediated by hypoxia-inducible factor-1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Physiol Cell Physiol (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1152/ajpcell.00075.2007"}], "href": "https://doi.org/10.1152/ajpcell.00075.2007"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17442736"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17442736"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "María Noel Galardo, María Fernanda Riera, Eliana Herminia Pellizzari, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Regulation of expression of Sertoli cell glucose transporters 1 and 3 by FSH, IL1 beta, and bFGF at two different time-points in pubertal development."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Tissue Res (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00441-008-0656-y"}], "href": "https://doi.org/10.1007/s00441-008-0656-y"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18802725"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18802725"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "David R Christensen, Philip C Calder, Franchesca D Houghton "}, {"type": "b", "children": [{"type": "t", "text": "GLUT3 and PKM2 regulate OCT4 expression and support the hypoxic culture of human embryonic stem cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/srep17500"}], "href": "https://doi.org/10.1038/srep17500"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26639784"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26639784"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "David Wu, Devin L Harrison, Teodora Szasz, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Single-cell metabolic imaging reveals a SLC2A3-dependent glycolytic burst in motile endothelial cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Metab (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s42255-021-00390-y"}], "href": "https://doi.org/10.1038/s42255-021-00390-y"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34031595"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34031595"}]}]}]}
Synonyms	GLUT3
Proteins	GTR3_HUMAN
NCBI Gene ID	6515
API
Download Associations
Predicted Functions
Co-expressed Genes
Expression in Tissues and Cell Lines

Functional Associations

SLC2A3 has 17,364 functional associations with biological entities spanning 9 categories (molecular profile, organism, chemical, functional term, phrase or reference, disease, phenotype or trait, structural feature, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 126 datasets.

Click the + buttons to view associations for SLC2A3 from the datasets below.

If available, associations are ranked by standardized value

Harmonizome 3.0

SLC2A3 Gene

Functional Associations

Please acknowledge the Harmonizome in your publications by citing the following reference(s):

	Dataset	Summary
	Achilles Cell Line Gene Essentiality Profiles	cell lines with fitness changed by SLC2A3 gene knockdown relative to other cell lines from the Achilles Cell Line Gene Essentiality Profiles dataset.
	Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles	tissues with high or low expression of SLC2A3 gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset.
	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	tissues with high or low expression of SLC2A3 gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset.
	Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles	tissue samples with high or low expression of SLC2A3 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset.
	Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray	tissue samples with high or low expression of SLC2A3 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset.
	Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq	tissue samples with high or low expression of SLC2A3 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset.
	Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles	tissues with high or low expression of SLC2A3 gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset.
	BioGPS Cell Line Gene Expression Profiles	cell lines with high or low expression of SLC2A3 gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset.
	BioGPS Human Cell Type and Tissue Gene Expression Profiles	cell types and tissues with high or low expression of SLC2A3 gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset.
	BioGPS Mouse Cell Type and Tissue Gene Expression Profiles	cell types and tissues with high or low expression of SLC2A3 gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset.
	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	small molecule perturbations changing expression of SLC2A3 gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset.
	CCLE Cell Line Gene CNV Profiles	cell lines with high or low copy number of SLC2A3 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset.
	CCLE Cell Line Gene Expression Profiles	cell lines with high or low expression of SLC2A3 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset.
	CCLE Cell Line Proteomics	Cell lines associated with SLC2A3 protein from the CCLE Cell Line Proteomics dataset.
	CellMarker Gene-Cell Type Associations	cell types associated with SLC2A3 gene from the CellMarker Gene-Cell Type Associations dataset.
	ChEA Transcription Factor Binding Site Profiles	transcription factor binding site profiles with transcription factor binding evidence at the promoter of SLC2A3 gene from the CHEA Transcription Factor Binding Site Profiles dataset.
	ChEA Transcription Factor Targets	transcription factors binding the promoter of SLC2A3 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset.
	ChEA Transcription Factor Targets 2022	transcription factors binding the promoter of SLC2A3 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset.
	CM4AI U2OS Cell Map Protein Localization Assemblies	assemblies containing SLC2A3 protein from integrated AP-MS and IF data from the CM4AI U2OS Cell Map Protein Localization Assemblies dataset.
	CMAP Signatures of Differentially Expressed Genes for Small Molecules	small molecule perturbations changing expression of SLC2A3 gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
	COMPARTMENTS Curated Protein Localization Evidence Scores	cellular components containing SLC2A3 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset.
	COMPARTMENTS Curated Protein Localization Evidence Scores 2025	cellular components containing SLC2A3 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset.
	COMPARTMENTS Text-mining Protein Localization Evidence Scores	cellular components co-occuring with SLC2A3 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset.
	COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025	cellular components co-occuring with SLC2A3 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset.
	COSMIC Cell Line Gene CNV Profiles	cell lines with high or low copy number of SLC2A3 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset.
	COSMIC Cell Line Gene Mutation Profiles	cell lines with SLC2A3 gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset.
	CTD Gene-Chemical Interactions	chemicals interacting with SLC2A3 gene/protein from the curated CTD Gene-Chemical Interactions dataset.
	CTD Gene-Disease Associations	diseases associated with SLC2A3 gene/protein from the curated CTD Gene-Disease Associations dataset.
	dbGAP Gene-Trait Associations	traits associated with SLC2A3 gene in GWAS and other genetic association datasets from the dbGAP Gene-Trait Associations dataset.
	DeepCoverMOA Drug Mechanisms of Action	small molecule perturbations with high or low expression of SLC2A3 protein relative to other small molecule perturbations from the DeepCoverMOA Drug Mechanisms of Action dataset.
	DepMap CRISPR Gene Dependency	cell lines with fitness changed by SLC2A3 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset.
	DISEASES Experimental Gene-Disease Association Evidence Scores 2025	diseases associated with SLC2A3 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset.
	DISEASES Text-mining Gene-Disease Association Evidence Scores	diseases co-occuring with SLC2A3 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset.
	DISEASES Text-mining Gene-Disease Association Evidence Scores 2025	diseases co-occuring with SLC2A3 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset.
	DisGeNET Gene-Disease Associations	diseases associated with SLC2A3 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset.
	DisGeNET Gene-Phenotype Associations	phenotypes associated with SLC2A3 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset.
	ENCODE Histone Modification Site Profiles	histone modification site profiles with high histone modification abundance at SLC2A3 gene from the ENCODE Histone Modification Site Profiles dataset.
	ENCODE Transcription Factor Binding Site Profiles	transcription factor binding site profiles with transcription factor binding evidence at the promoter of SLC2A3 gene from the ENCODE Transcription Factor Binding Site Profiles dataset.
	ENCODE Transcription Factor Targets	transcription factors binding the promoter of SLC2A3 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset.
	ESCAPE Omics Signatures of Genes and Proteins for Stem Cells	PubMedIDs of publications reporting gene signatures containing SLC2A3 from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset.